Producenci
16:0 Monolysocardiolipin (MCL)
16:0 Monolysocardiolipin (MCL)
18:1 LysoPEth
18:1 LysoPEth
18:1 TAP (DOTAP)
18:1 TAP (DOTAP)
18:1 TAP (DOTAP)
18:2 LysoPC
18:2 LysoPC
18:2 LysoPC-d9
18:2 LysoPC-d9
1D-O-(1, 2-Di-O-oleoyl-sn-(2S)-glycerol-3-phospho)-3-(phosphothionate)-myo-inositol
1D-O-(1, 2-Di-O-oleoyl-sn-(2S)-glycerol-3-phospho)-3-(phosphothionate)-myo-inositol
1R, 2R-B13 (Ceramidase inhibitor)
1R, 2R-B13 (Ceramidase inhibitor)
1R, 2R-B13 (Ceramidase inhibitor)
2-Acetyl-5-tetrahydroxybutyl imidazole (THI)
2-Acetyl-5-tetrahydroxybutyl imidazole (THI)
2-Acetyl-5-tetrahydroxybutyl imidazole (THI)
2-C-Methyl-D-erythritol 2, 4-cyclophosphate (cMEPP)
2-C-Methyl-D-erythritol 2, 4-cyclophosphate (cMEPP)
2-C-Methyl-D-erythritol 4-phosphate (MEP)
2-C-Methyl-D-erythritol 4-phosphate (MEP)
2-C-Methyl-D-erythritol 4-phosphate (MEP)
2-C-Methyl-erythritol (ME)
2-C-Methyl-erythritol (ME)
2-C-Methyl-erythritol (ME)
2-Furoyl-LIGR-Amide (Protease-Activated Receptor 2 (PAR2) Agonist)
2-Furoyl-LIGRL-Amide (Protease-Activated Receptor 2 (PAR2) Agonist)
2-Furoyl-LIGRLO-NH2 (Potent and Selective Protease-Activated Receptor 2 (PAR2) Agonist)